TTK Healthcare Limited

Equities

TTKHLTCARE

INE910C01018

Pharmaceuticals

Delayed Bombay S.E. 06:00:53 2024-06-10 am EDT 5-day change 1st Jan Change
1,465 INR +0.82% Intraday chart for TTK Healthcare Limited +0.16% +3.97%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
TTK Healthcare Names CEO MT
TTK Healthcare Limited Announces Management Changes, Effective June 1, 2024 CI
TTK Healthcare Limited Announces Executive Changes with Effect from 1 June, 2024 CI
TTK Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
TTK Healthcare Limited Recommends Dividend for the Financial Year Ended 31 March, 2024 CI
TTK Healthcare Resumes Production at Foods Division Factory in Jaipur, India MT
TTK Healthcare Sees Production Disruption at Foods Division Factory in Jaipur, India MT
TTK Healthcare Limited Appoints S Kalyanaraman as Chief Executive Officer, Effective 1 June, 2024 CI
TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
TTK Healthcare's Production at Chennai, Unit Disrupted Due to Floods MT
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
TTK Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan cancelled the acquisition of remaining 26.888% shares in TTK Healthcare Limited. CI
TTK Healthcare Revises Floor Price for Delisting MT
India's Mankind Pharma posts 43% jump in Q4 profit in first results since listing RE
TTK Healthcare Logs Higher Net Profit in Fiscal Q4 MT
TTK Healthcare Limited Proposes Dividend for the Financial Year Ended 31St March, 2023 CI
TTK Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
TT Krishnamachari & Co., Ltd., T T Jagannathan, and T T Raghunathan, made an offer to acquire remaining 26.888% shares in TTK Healthcare Limited. CI
TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
TTK Healthcare Posts Decline in Fiscal Q2 Consolidated Net Profit MT
India's TTK Healthcare Q2 profit more than doubles on higher sales of medical devices RE
TTK Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
TTK Healthcare Appoints New Chairman MT
Chart TTK Healthcare Limited
More charts
TTK Healthcare Limited is an India-based company, which provides consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods and Others. The Animal Welfare segment comprises products for veterinary use. The Consumer Products segment comprises marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, good home range of scrubbers, air fresheners and various others. Its brands also include Skore and HUG n WAG. The Medical Devices segment includes artificial heart valves, orthopedic implants and others. The Protective Devices segment comprises manufacturing and marketing of male contraceptives and other allied products. The Foods segment comprises manufacturing and marketing of food products. Under the brand name Fryums, extruded products such as papads are offered to its business to business and export customers. The Others segment includes printing and publishing of maps and atlases.
More about the company
  1. Stock Market
  2. Equities
  3. TTKHLTCARE Stock
  4. News TTK Healthcare Limited
  5. TTK Healthcare to Sell Human Pharmaceutical Business to BSV Pharma for $106 Million; Shares Soar 12%